New Key Statistics Module, Z-Score and F-Score
OTCPK:OPHLY Key Ratios
Market Cap $ M | 6,481.77 |
Enterprise Value $ M | 5,131.92 |
P/E(ttm) | 8.10 |
PE Ratio without NRI | 8.10 |
Forward PE Ratio | 11.90 |
Price/Book | 1.17 |
Price/Sales | 1.83 |
Price/Free Cash Flow | 9.01 |
Price/Owner Earnings | 9.05 |
Payout Ratio % | 0.31 |
Revenue (TTM) $ M | 3,347.00 |
EPS (TTM) $ | 0.57 |
Beneish M-Score | -2.21 |
10-y EBITDA Growth Rate % | 21.40 |
5-y EBITDA Growth Rate % | 20.40 |
y-y EBITDA Growth Rate % | 14.40 |
EV-to-EBIT | 4.76 |
EV-to-EBITDA | 4.27 |
PEG | 0.40 |
Shares Outstanding M | 1,409.08 |
Net Margin (%) | 24.17 |
Operating Margin % | 29.84 |
Pre-tax Margin (%) | 30.91 |
Quick Ratio | 3.52 |
Current Ratio | 3.99 |
ROA % (ttm) | 13.57 |
ROE % (ttm) | 15.67 |
ROIC % (ttm) | 17.78 |
Dividend Yield % | 3.79 |
Altman Z-Score | 7.40 |
OPHLY Number of Guru Trades
OPHLY Volume of Guru Trades
Gurus Latest Trades with OTCPK:OPHLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OPHLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ono Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:OPHLY
Total 0- 1